Results 61 to 70 of about 176,903 (205)

Adverse Reactions Identified after Approval of Novel Medicines: Analysis of 339 New Molecular Entities and Therapeutic Biologics

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 1120-1128, October 2026.
Postmarketing safety surveillance data identify safety issues not identified in preapproval clinical trials. We describe the frequency of new safety issues overall and by labeling section and the relationship of the most commonly added safety issues with the cumulative number of prescriptions dispensed via retail pharmacies.
Ellen Pinnow, Brendan Day, Esther H. Zhou, Corinne Woods, Nana Dwumfour, Jenni Y. Lee, Ilynn Bulatao, Sanae Cherkaoui, Manish Kalaria, Sonja Brajovic, Nabila Sadiq, Farideh Sistani, Maggie Lee, Grace Chai, Gerald Dal Pan   +14 more
wiley   +1 more source

Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia [PDF]

, 2012
Pneumocystis jirovecii is an important opportunistic infection in HIV-infected patients. In the developed world, P. jirovecii epidemiology is marked by frequent colonization in immunosuppressed patients, but data on the prevalence of colonization is very
Taylor, Steve M., Goodman, Carol D., Samuel D. Yoo, Alfred Andama, den Boon, Saskia, Worodria, William, Meshnick, Steven R., Andama, Alfred, Steve M. Taylor, Huang, Laurence, J. Lucian Davis, Laurence Huang, William Worodria, Carol D. Goodman, Adithya Cattamanchi, Saskia den Boon, Davis, J. Lucian, Steven R. Meshnick, Cattamanchi, Adithya, Yoo, Samuel D.   +19 more
core   +1 more source

Pneumocystis jirovecii

, 2023
Tato bakalářská práce se zabývá atypickým mikroorganismem Pneumocystis jirovecii, způsobující pneumonie u pacientů s oslabeným imunitním systémem. Věnuje se její charakteristice, onemocnění, laboratorní diagnostice a léčbě.
Nováková, Lenka
core   +1 more source

Bone Marrow Infection by Pneumocystis jirovecii in a Patient with AIDS: A Case Report and Literature Review

Infectious Disease Reports
Background: Pneumocystis jirovecii primarily causes pneumonia in immunosuppressed individuals, particularly those living with advanced HIV/AIDS. Extrapulmonary dissemination is uncommon, with bone marrow involvement described in only a handful of cases ...
Diego Alejandro Cubides-Diaz, Valentina Negrette-Lazaro, Viviana Poveda-Hurtado, Juan Pablo López-Salazar, Carlos Mauricio Calderón-Vargas, Carlos Arturo Álvarez-Moreno   +5 more
doaj   +1 more source

Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time

Emerging Infectious Diseases, 2013
In a previous cross-sectional study, we showed that clinical staff working in a hospital had significantly higher antibody levels than nonclinical staff to Pneumocystis jirovecii.
Serena Fong, Kieran R. Daly, Renuka Tipirneni, Leah G. Jarlsberg, Kpandja Djawe, Judy V. Koch, Alexandra Swartzman, Brenna Roth, Peter D. Walzer, Laurence Huang   +9 more
doaj   +1 more source

The Power of Hematopoietic Stem Cell Transplantation (HSCT): A Curative Approach for Diffuse Large B‐Cell Lymphoma (DLBCL) Incidentally Detected in a SCID Baby

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Lymphoma is a rare complication of X‐linked severe combined immunodeficiency (X‐SCID) caused by IL2RG deficiency. We report an infant with IL2RG‐SCID who developed diffuse large B‐cell lymphoma (DLBCL) during pretransplant evaluation. A male infant with T−B+ SCID was diagnosed at 1 month of age and referred for hematopoietic stem cell ...
Burcu Sarıgül Cimi, Sule Haskologlu, Candan Islamoglu, Gokcan Ozturk, Nazlı Deveci, Hasret Erkmen, Selin Sevinc, Can Akal, Seda Kaynak Sahap, Sonay Özdemir, Suat Fitoz, Isınsu Kuzu, Emel Unal, Nurdan Tacyıldız, Figen Dogu, Aydan Ikinciogullari   +15 more
wiley   +1 more source

Pneumocystis jirovecii pneumonia: an old disease with a new name. [PDF]

, 2006
Pneumocystis jirovecii pneumonia has historically been one of the most common opportunistic pneumonias and life-threatening infectious complications in HIV-infected patients.
Aleksonienė, Regina,, Matulionytė, Raimonda,, Ambrozaitis, Arvydas,, Paulauskienė, Rasute,   +3 more
core  

Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

, 2018
Pneumocystis jirovecii pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy.
William Greene, J. T. Fannin, Allison Bragg, Patrick K. Campbell, Kristine R. Crews, Joseph Sciasci, Jennifer L. Pauley, Melissa Quinn, Sima Jeha, Delia Carias, David Gregornik, Gabriela Maron, Joshua Wolf, Hope D. Swanson   +13 more
core   +1 more source

Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer [PDF]

, 2014
Everolimus is an inhibitor of mammalian target of rapamycin with anti-tumour activity. While everolimus is known to cause drug-induced pneumonitis, it is rarely associated with Pneumocystis jirovecii pneumonia (PJP).
Jason Trubiano, Johnson, D, Daniel Steinfort, Kuik, KTH, Worth, LJ, Harun, NS, Leon J. Worth, Nur-shirin Harun, Steinfort, D, Kelvin Teck-Hong Kuik, Trubiano, J, Douglas Johnson   +11 more
core   +1 more source

Trichosporon asahii co-infection with Pneumocystis jiroveci in a renal transplant patient

IDCases
Trichosporon asahii is considered an opportunistic pathogen, capable of causing superficial infections in humans and invasive deep-seated infections in immunocompromised hosts.
Tingting Yang, Yajie Fu
doaj   +1 more source